Fort Washington Investment Advisors Inc Gilead Sciences, Inc. Transaction History
Fort Washington Investment Advisors Inc
- $15.8 Billion
- Q1 2025
A detailed history of Fort Washington Investment Advisors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 309,891 shares of GILD stock, worth $32.7 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
309,891
Previous 376,047
17.59%
Holding current value
$32.7 Million
Previous $34.7 Million
0.03%
% of portfolio
0.22%
Previous 0.21%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,138Shares Held
988MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$12.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.2 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.57 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.37 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.11 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $132B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...